Millipore Sigma Vibrant Logo

324801 InSolution™ Epoxomicin, Synthetic - Calbiochem

InSolution™ Epoxomicin, Synthetic, is a 1 mM solution of Epoxomicin, Synthetic (Cat. No. 324800) in DMSO.

InSolution™ Epoxomicin, Synthetic - Calbiochem: のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。

同義語: Proteasome Inhibitor XIV

Primary Target: CT-L,T-L,PGPH activity of proteasome
View This Product on Sigma-Aldrich
324801
価格＆在庫状況を照会

概要

Replacement Information

主要スペック表

Empirical Formula
C₂₈H₅₀N₄O₇

価格＆在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
324801-50UGCN
在庫状況検索中…
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      		 樹脂ｱﾝﾌﾟﾙ 50 μg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示　
      値引
      ()
       
      —
      弊社照会
      		 —
      Description
      Catalogue Number324801
      Brand Family Calbiochem®
      SynonymsProteasome Inhibitor XIV
      References
      ReferencesMeng, L., et al. 1999. Proc. Natl. Acad. Sci. USA 96, 10403.
      Sin, N., et al. 1999. Bioorg. Med. Chem. Lett. 9, 2283.
      Hanada, M., et al. 1992. J. Antibiot. 45, 1746.
      Product Information
      ATP CompetitiveN
      FormLiquid
      FormulationA 1 mM (50 µg/90 µl) solution of Epoxomicin, Synthetic (Cat. No. 324800) in DMSO.
      Hill FormulaC₂₈H₅₀N₄O₇
      Chemical formulaC₂₈H₅₀N₄O₇
      Hygroscopic Hygroscopic
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetCT-L,T-L,PGPH activity of proteasome
      Purity≥95% by HPLC
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped with Blue Ice or with Dry Ice
      Toxicity Irritant
      Storage -20°C
      Protect from Light Protect from light
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      324801-50UGCN 04055977216165

      Documentation

      InSolution™ Epoxomicin, Synthetic - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート（(M)SDS） 

      InSolution™ Epoxomicin, Synthetic - Calbiochem 試験成績書（CoA）

      タイトルロット番号
      324801

      参考資料

      参考資料の概要
      Meng, L., et al. 1999. Proc. Natl. Acad. Sci. USA 96, 10403.
      Sin, N., et al. 1999. Bioorg. Med. Chem. Lett. 9, 2283.
      Hanada, M., et al. 1992. J. Antibiot. 45, 1746.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision20-June-2008 RFH
      SynonymsProteasome Inhibitor XIV
      DescriptionAn antitumor agent of microbial origin that acts as a potent, highly specific, and irreversible inhibitor of chymotrypsin-like (CT-L), trypsin-like (T-L), and peptidylglutamyl peptide hydrolyzing (PGPH) activities of the proteasome. Modifies the proteasomal catalytic subunits LMP-7, MECL1, and Z. Epoxomicin also displays potent anti-inflammatory activity in vivo.
      FormLiquid
      FormulationA 1 mM (50 µg/90 µl) solution of Epoxomicin, Synthetic (Cat. No. 324800) in DMSO.
      Intert gas (Yes/No) Packaged under inert gas
      Chemical formulaC₂₈H₅₀N₄O₇
      Structure formulaStructure formula
      Purity≥95% by HPLC
      Storage Protect from light
      -20°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
      Toxicity Irritant
      ReferencesMeng, L., et al. 1999. Proc. Natl. Acad. Sci. USA 96, 10403.
      Sin, N., et al. 1999. Bioorg. Med. Chem. Lett. 9, 2283.
      Hanada, M., et al. 1992. J. Antibiot. 45, 1746.